Report cards › Food › Rich Products Corporation

FARM RICH

Owned by Rich Products Corporation · 117 products in USDA FoodData Central · as of Oct 28, 2026 · Report an error · Change log

CSWH grade B (83)

Method v1.0 (how we grade), based on the records below; exact score 83.2393.

Grade by indicator
IndicatorGradeWhat we found
Recalls (40%)B (80)1 Class II (4 points) · 1 event For current recalls see FDA and USDA.
Ingredients (40%)B (78)Tier A: 0 of 117 products · A (100) (25%)
Tier B: 41 of 117 products (Bleached flour, Butylated hydroxyanisole (BHA), Butylated hydroxytoluene (BHT), FD&C Red No. 40, FD&C Yellow No. 5, FD&C Blue No. 1 and 6 more) · D (42) (15%) · products
FDA warning letters (20%)A (100)None found to the owner Oct 28, 2021 to Oct 28, 2026.

Shown, not graded: recall reasons (1 foreign material) · IARC notes (9 products) · FDA dye pledge: none on FDA's tracker.

Recalls, Oct 28, 2021 to Oct 28, 2026

  1. Class II, May 19, 2026 · Foreign material · FDA event 99022

    • Farm Rich Pizza Cheese Crunchers

      Reason (FDA's words)
      May contain metal pieces
      Code information
      Lot/Unit Numbers: 003029976 Best by 7/30/27 UPC Codes: 041322652256
      Recalling firm
      Rich Products Corp
      Dates
      Recall started May 19, 2026; classified Jun 9, 2026
      Status
      Terminated (status reported by FDA at classification)
      How we matched it
      matched by UPC 41322652256 (upc)

      FDA record H-0912-2026: openFDA · Report an error

3 recall events by Rich Products Corporation name no brand, so they are on the owner's page, not counted here.

Store-brand and co-packer recalls count on a brand only when a UPC in the recall matches one of its products.

Ingredients on our watch list

Products (46)

Show all 46 products

Labels change: each row shows the date of its FoodData Central record. A brand that has changed a recipe can report it with "Report an error".

FDA warning letters to Rich Products Corporation, Oct 28, 2021 to Oct 28, 2026

None found from FDA food offices.

FDA notes that later events may have changed the regulatory status of what a letter discusses.